The field of antiviral therapy is expanding at an unprecedented rate. The tremendous expansion in drug screening and rational drug design brought about by the HIV pandemic, together with gathering interest in new viral targets' such as the hepatitis and papillomaviruses, means that more antiviral agents than ever are reaching clinical trials. Several journals now deal exclusively with the chemistry, design and pre-clinical development of antiviral agents. Previously, however, publications concerning clinical aspects of antiviral therapy have been dispersed among a wide range of different journals, making it increasingly difficult to keep abreast of this multidisciplinary field. Antiviral Therapy is the first international journal solely devoted to the clinical development and use of antiviral agents. It publishes original scientific papers in all therapeutic areas, including: results of clinical studies in all phases; viral diagnostics and individualization of antiviral therapy; study design issues in the clinical assessment of antivirals; antiviral drug safety and safety monitoring; mechanisms of resistance to antiviral agents; pharmacoepidemiology of viral diseases. Antiviral Therapy also features review articles, editorials, book reviews and a letters section to provide a forum for discussion. Antiviral Therapy is an official publication of the International Society for Antiviral Research

抗病毒治療領(lǐng)域正以前所未有的速度擴展。艾滋病帶來的藥物篩選和合理藥物設計的巨大擴展，加上對肝炎和乳頭狀瘤病毒等新的病毒目標的興趣的聚集，意味著比以往任何時候都更多的抗病毒藥物進入了臨床試驗。一些期刊現(xiàn)在專門討論抗病毒藥物的化學、設計和臨床前的發(fā)展。然而，以前有關(guān)抗病毒治療的臨床方面的出版物分散在各種不同的期刊中，使人們越來越難以跟上這一多學科領(lǐng)域的發(fā)展。《抗病毒治療》是第一個專門用于臨床開發(fā)和使用抗病毒藥物的國際期刊。它出版所有治療領(lǐng)域的原始科學論文，包括：各階段的臨床研究結(jié)果；抗病毒治療的病毒診斷和個體化；抗病毒藥物臨床評估中的研究設計問題；抗病毒藥物的安全和監(jiān)測；抗病毒藥物抗性機制；病毒疾病的藥物流行病學。抗病毒療法還包括評論文章、社論、書評和信件部分，為討論提供一個論壇。抗病毒治療是國際抗病毒研究學會的官方出版物